DA LI JE OPRAVDANA LEGALIZACIJA MEDICINSKE I REKREATIVNE UPOTREBE KANABISA?
Sažetak
Sažetak: Kanabis je droga koja je najrasprostranjenija na tržištu u gotovo svim zemljama sveta. S obzirom da spada u grupu tzv. lakih droga i da se pod određenim uslovima koristi u medicinske svrhe, može se postaviti pitanje da li je opravdano legalizovati upotrebu kanabisa. Ovaj problem je aktuelan, jer su pojedine zemlje već legalizovale medicinsku, odnosno rekreativnu upotrebu kanabisa. U radu će biti obrazloženo naše stanovište da je opravdana legalizacija medicinske upotrebe ove biljke. Suprotno tome, zauzeli smo stav da legalizacija komercijalne prodaje i rekreativne upotrebe kanabisa nije prihvatljiva. Pri analizi naučnih radova smo koristili metod analize sadržaja. Takođe, koristili smo metod dedukcije i indukcije, kao i metod sinteze.
Reference
Adams, I. B., Martin, B. R. (1996). Cannabis: pharmacology and toxicology in animals and humans, Addiction, 11: 1585-1614.
Andreasson, S., Engstrom, A., Allebeck, P., Rydberg, U. (1987). Cannabis and schizophrenia. A longitudinal study of Swedish conscripts, The Lancet, 330 (8574): 1483-1486.
Borodovskya, J. T., Budney, A. J. (2017). Legal cannabis laws, home cultivation, and use of edible cannabis products: A growing relationship?, International Journal of Drug Policy, 50: 102-110.
Caulkins, J. P., Kilmer, B., MacCoun, R.J., Pacula, R.L., Reuter, P. (2012). Design considerations for legalizing cannabis: lessons inspired by analysis of California’s Proposition 19, Addiction, 107(5): 865-871.
Cerdá, M., Wall, M., Keyes, K.M., Galea, S., Hasin, D. (2012). Medical marijuana laws in 50 states: Investigating the relationship between state legalization of medical marijuana and marijuana use, abuse and dependence, Drug and Alcohol Dependence, 120(1-3): 22-27.
Decorte, T. (2010). The case for small-scale domestic cannabis cultivation, International Journal of Drug Policy, 4: 271-275.
Elliott, A.J., Chapman, S. (2000). Heroin hell their own making‘: construction of heroin users in the Australian press 1992–97, Drug and Alcohol Review, 19: 191-201.
Fankhauser, M. (2008). A cannabis reader: global issues and local experiences, EMCDDA, Lisbon.
Ferraiolo, K. (2007). From Killer Weed to Popular Medicine: The Evolution of American Drug Control Policy, 1937–2000, Journal of Policy History, (19)2: 147-179.
Hall, W., Degenhardt, L. (2009). Adverse health effects of non-medical cannabis use, The Lancet, 374 (9698): 1383-1391.
Hazekamp, A. (2006). An evaluation of the quality of medicinal grade cannabis in the Netherlands, Cannabinoids, 1: 1-9.
Hough, M., Warburton, H., Few, B., May, T., Man, L., Witton, J., Turnbull, P.J. (2003). A growing market The domestic cultivation of cannabis, Joseph Rowntree Foundation, York.
Khatapoush, S., Hallfors, D. (2004). “Sending the Wrong Message”: Did Medical Marijuana Legalization in California Change Attitudes about and use of Marijuana? Journal of Drug Issues, 34(4): 751-770.
Lajic, O. (2016). Percepcija narkomanije i narko-kriminala u opštoj populaciji i populaciji studenata KPA, Nauka, bezbednost, policija, 21 (3): 39-60.
McLaren, J., Swift W., Dillon, P., Allsop, S. (2008). Cannabis potency and contamination: a review of the literature, Addiction, 103(7): 1100-1109.
Pacula, R.L., Powell, D., Heaton, P., Sevigny, E.L. (2015). Assessing the Effects of Medical Marijuana Laws on Marijuana Use: The Devil is in the Details, Policy Analysis and Management, 34 (1): 7-31.
Pacula, R.L., Kilmer, B., Wagenaar, A., Chaloupka, F.J., Caulkins, J.P. (2014). Developing Public Health Regulations for Marijuana: Lessons From Alcohol and Tobacco, American Journal of Public Health, 104 (6): 1021-1028.
Subritzky, T., Pettigrew, S., Lenton, S. (2017). Into the void: Regulating pesticide use in Colorado’s commercial cannabis markets, International Journal of Drug Policy, 42: 86-96.
Sun, Y., Bennett, A. (2007). „Cannabinoids: A New Group of Agonists of PPARs”, PPAR Research, 2007: 1-7.
Svetlana Goločorbin-Kon, Pavlović, N., Rašković, A., Lalić-Popovac, M., Milić, N., Milošević, N., Milkov, M. (2015). Primena kanabisa u medicini i farmaciji, Medicinski časopis, 49(4): 130-138.
Sznitman, S.R., Lewis, N. (2018). Examining effects of medical cannabis narratives on beliefs, attitudes, and intentions related to recreational cannabis: A web-based randomized experiment, Drug and Alcohol Dependence, 185: 219-225.
Sznitman, S.R., Lewis, N. (2015). Is cannabis an illicit drug or a medicine? A quantitative framing analysis of Israeli newspaper coverage, International Journal of Drug Policy, 26(5): 446-452.
Taylor, S. (2008). Outside the outsiders: Media representations of drug use, The Journal of Community and Criminal Justice, 55(4): 369-387.
Touw, M. (1981). The religious and medicinal uses of Cannabis in China, India and Tibet, Journal of Psychoactive Drugs, 13 (1): 23-34.
United Nations Office on Drugs and Crime. (2006). World Drug Report. Vol. 1. Analysis. New York. (https://www.unodc.org/pdf/WDR_2006/wdr2006_volume1.pdf)
Vandrey, R., Herrmann, E.S., Mitchell, J.M., Bigelow, G.E., Flegel, R., LoDico, C., Cone, E.J. (2017).Pharmacokinetic Profile of Oral Cannabis in Humans: Blood and Oral Fluid Disposition and Relation to Pharmacodynamic Outcomes, Journal of Analytical Toxicology, 41(2): 83-99.
Wall, M.M., Poh, E., Cerda, M., Keyes, K.M., Galea, S., Hasin, D.S. (2011). Adolescent Marijuana Use from 2002 to 2008: Higher in States with Medical Marijuana Laws, Cause Still Unclear, Annals of Epidemiology, 21 (9): 714-716.
Zuardi, A. W. (2006). History of cannabis as a medicine: a review, Revista Brasileira de Psiquiatria, 2: 153-157.